Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 03-2017 | 12-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,540 | 0 | 9,995 | 0 | 9,995 |
| Marketable Securities | 40,854 | 0 | 69,156 | 0 | 69,156 |
| Other current assets | 0 | 0 | 5,000 | 0 | 14,024 |
| TOTAL | $71,330 | $0 | $93,175 | $0 | $93,175 |
| Non-Current Assets | |||||
| PPE Net | 7,326 | 0 | 3,877 | 0 | 3,877 |
| Other Non-Current Assets | 2,798 | 0 | 1,087 | 0 | 0 |
| TOTAL | $10,124 | $0 | $4,964 | $0 | $3,877 |
| Total Assets | $81,454 | $0 | $98,139 | $0 | $98,139 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,215 | 0 | 2,845 | 0 | 0 |
| Accrued Expenses | 9,843 | 0 | 6,336 | 0 | N/A |
| TOTAL | $23,384 | $0 | $16,207 | $0 | $16,207 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,326 | 0 | 7,026 | 0 | N/A |
| Other Non-Current Liabilities | 48,517 | 0 | 48,477 | 0 | 0 |
| TOTAL | $125,384 | $0 | $108,844 | $0 | $N/A |
| Total Liabilities | $148,768 | $0 | $125,051 | $0 | $125,051 |
| Shareholders' Equity | |||||
| Retained earnings | -73,945 | 0 | -28,568 | 0 | -28,568 |
| Other shareholders' equity | -246 | 0 | -384 | 0 | 1,656 |
| TOTAL | $-67,314 | $0 | $-26,912 | $0 | $-26,912 |
| Total Liabilities And Equity | $81,454 | $0 | $98,139 | $0 | $98,139 |